Although active cancer is recognised as a risk factor for increased bleeding, the specific bleeding risks associated with ...

Research Group in Valvular Heart Disease, Laval Hospital Research Centre/Quebec Heart Institute, Laval University, Sainte-Foy, Quebec, Canada Correspondence to: Dr Philippe Pibarot Laval Hospital ...

Correspondence to Dr Pierre-Antoine Dugué, Cancer Epidemiology and Intelligence Division, Cancer Council Victoria, Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global ...

Introduction Traditionally, patients are kept nil-per-os/nil-by-mouth (NPO/NBM) prior to invasive cardiac procedures, yet there exists neither evidence nor clear guidance about the benefits of this ...

1 Department of Cardiology, St Vincent's Hospital, Melbourne, Australia 2 Department of Medicine, St Vincent's Hospital, University of Melbourne, Melbourne, Australia 3 Department of Cardiovascular ...

Correspondence to: Michael Weber MD, Kerckhoff Heart Center, Department of Cardiology, Benekestraße 2–8, 61231 Bad Nauheim, Germany; M.Weber{at}kerckhoff-klinik.de In recent years biomarkers have ...

1 Dipartimento di Scienze Biomediche e Chirurgiche, Università di Verona, Verona, Italy 2 Dipartimento Cardiaco, Toracico e Vascolare, Università di Pisa, Pisa, Italy Background Functional mitral ...

BHF Health Promotion Research Group, Division of Public Health and Primary Health Care, University of Oxford, UK Dr M O’Flaherty, Division of Public Health, Whelan Building, Quadrangle, University of ...

Correspondence to Dr Prachi Bhatnagar, British Heart Foundation Centre on Population Approaches for Non-Communicable Disease Prevention, Nuffield Department of Population Health, Old Road Campus, ...

Objective Distinguishing early dilated cardiomyopathy (DCM) from physiological left ventricular (LV) dilatation with LV ejection fraction <55% in athletes (grey zone) is challenging. We evaluated the ...

Objective To study the association of self-reported physical activity level with prognosis in a cohort of patients with coronary heart disease (CHD), with a special focus on the dose–response ...